WallStSmart

Select Medical Holdings (SEM) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Select Medical Holdings stock (SEM) is currently trading at $16.29. Select Medical Holdings PE ratio is 14.03. Select Medical Holdings PS ratio (Price-to-Sales) is 0.37. Analyst consensus price target for SEM is $16.62. WallStSmart rates SEM as Underperform.

  • SEM PE ratio analysis and historical PE chart
  • SEM PS ratio (Price-to-Sales) history and trend
  • SEM intrinsic value — DCF, Graham Number, EPV models
  • SEM stock price prediction 2025 2026 2027 2028 2029 2030
  • SEM fair value vs current price
  • SEM insider transactions and insider buying
  • Is SEM undervalued or overvalued?
  • Select Medical Holdings financial analysis — revenue, earnings, cash flow
  • SEM Piotroski F-Score and Altman Z-Score
  • SEM analyst price target and Smart Rating
SEM

Select Medical Holdings

NYSEHEALTHCARE
$16.29
$0.02 (0.12%)
52W$11.49
$18.27
Target$16.62+2.0%

📊 No data available

Try selecting a different time range

IV

SEM Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Select Medical Holdings (SEM)

Margin of Safety
-105.7%
Significantly Overvalued
SEM Fair Value
$7.89
Graham Formula
Current Price
$16.29
$8.40 above fair value
Undervalued
Fair: $7.89
Overvalued
Price $16.29
Graham IV $7.89
Analyst $16.62

SEM trades 106% above its Graham fair value of $7.89, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Select Medical Holdings (SEM) · 10 metrics scored

Smart Score

51
out of 100
Grade: C-
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, institutional own.. Concerns around operating margin and eps growth. Fundamentals are solid but monitor weak areas for improvement.

Select Medical Holdings (SEM) Key Strengths (4)

Avg Score: 8.8/10
Price/SalesValuation
0.3710/10

Paying less than $1 for every $1 of annual revenue

Institutional Own.Quality
82.61%10/10

82.61% of shares held by major funds and institutions

Price/BookValuation
1.188/10

Trading at 1.18x book value, attractively priced

Market CapQuality
$2.02B7/10

Mid-cap company balancing growth potential with stability

Supporting Valuation Data

P/E Ratio
14.03
Undervalued
Forward P/E
12.92
Attractive
Trailing P/E
14.03
Undervalued
Price/Sales (TTM)
0.37
Undervalued
EV/Revenue
0.891
Undervalued

Select Medical Holdings (SEM) Areas to Watch (6)

Avg Score: 2.7/10
EPS GrowthGrowth
-46.80%0/10

Earnings declining -46.80%, profits shrinking

Operating MarginProfitability
4.58%1/10

Near-zero operating margins, business under pressure

Profit MarginProfitability
2.68%2/10

Very thin margins, barely profitable

PEG RatioValuation
2.264/10

Paying a premium for growth, expensive relative to earnings expansion

Revenue GrowthGrowth
7.20%4/10

Modest revenue growth at 7.20%

Return on EquityProfitability
10.60%5/10

Moderate profitability with room for improvement

Select Medical Holdings (SEM) Detailed Analysis Report

Overall Assessment

This company scores 51/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.8/10) while 6 fall into concern territory (avg 2.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Institutional Own., Price/Book. Valuation metrics including Price/Sales (0.37), Price/Book (1.18) suggest the stock is attractively priced.

The Bear Case

The primary concerns are EPS Growth, Operating Margin, Profit Margin. Some valuation metrics including PEG Ratio (2.26) suggest expensive pricing. Growth concerns include Revenue Growth at 7.20%, EPS Growth at -46.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 10.60%, Operating Margin at 4.58%, Profit Margin at 2.68%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 10.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 7.20% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Price/Sales, Institutional Own.) and negatives (EPS Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

SEM Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

SEM's Price-to-Sales ratio of 0.37x sits near its historical average of 0.37x (29th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 0.37x set in Mar 2026, and 9% above its historical low of 0.34x in Mar 2026.

Compare SEM with Competitors

Top MEDICAL CARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Select Medical Holdings (SEM) · HEALTHCAREMEDICAL CARE FACILITIES

The Big Picture

Select Medical Holdings is a mature, profitable business with steady cash generation. Revenue reached 5.5B with 7% growth year-over-year. Profit margins are strong at 268.0%, reflecting pricing power and operational efficiency.

Key Findings

Excellent Capital Efficiency

ROE of 1060.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

Strong Profitability

Profit margin of 268.0% and operating margin of 458.0% demonstrate strong pricing power and operational efficiency.

What to Watch Next

Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Select Medical Holdings.

Bottom Line

Select Medical Holdings is a well-established business delivering consistent profitability with 268.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Select Medical Holdings(SEM)

Exchange

NYSE

Sector

HEALTHCARE

Industry

MEDICAL CARE FACILITIES

Country

USA

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company is headquartered in Mechanicsburg, Pennsylvania.